414 related articles for article (PubMed ID: 25745821)
1. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
[TBL] [Abstract][Full Text] [Related]
2. Hepcidin and GDF-15 are potential biomarkers of iron deficiency anaemia in chronic kidney disease patients in South Africa.
Nalado AM; Olorunfemi G; Dix-Peek T; Dickens C; Khambule L; Snyman T; Paget G; Mahlangu J; Duarte R; George J; Naicker S
BMC Nephrol; 2020 Sep; 21(1):415. PubMed ID: 32993549
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the Iron Homeostatic Hormone Hepcidin.
Sangkhae V; Nemeth E
Adv Nutr; 2017 Jan; 8(1):126-136. PubMed ID: 28096133
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of the serum transferrin receptor in detecting iron deficiency in the anemia of chronic disorders.
Juncà J; Fernández-Avilés F; Oriol A; Navarro JT; Millá F; Sancho JM; Feliu E
Haematologica; 1998 Aug; 83(8):676-80. PubMed ID: 9793248
[TBL] [Abstract][Full Text] [Related]
5. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.
Zoller H; McFarlane I; Theurl I; Stadlmann S; Nemeth E; Oxley D; Ganz T; Halsall DJ; Cox TM; Vogel W
Hepatology; 2005 Aug; 42(2):466-72. PubMed ID: 15986403
[TBL] [Abstract][Full Text] [Related]
6. Current understanding of iron homeostasis.
Anderson GJ; Frazer DM
Am J Clin Nutr; 2017 Dec; 106(Suppl 6):1559S-1566S. PubMed ID: 29070551
[TBL] [Abstract][Full Text] [Related]
7. Erythroblast iron metabolism and serum soluble transferrin receptor values in the anemia of rheumatoid arthritis.
Fitzsimons EJ; Houston T; Munro R; Sturrock RD; Speekenbrink AB; Brock JH
Arthritis Rheum; 2002 Apr; 47(2):166-71. PubMed ID: 11954010
[TBL] [Abstract][Full Text] [Related]
8. Effect of ferroportin Q248H polymorphism on iron status in African children.
Kasvosve I; Gomo ZA; Nathoo KJ; Matibe P; Mudenge B; Loyevsky M; Gordeuk VR
Am J Clin Nutr; 2005 Nov; 82(5):1102-6. PubMed ID: 16280445
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of iron deficiency in chronic renal failure.
Fernández-Rodríguez AM; Guindeo-Casasús MC; Molero-Labarta T; Domínguez-Cabrera C; Hortal-Casc n L; Pérez-Borges P; Vega-Díaz N; Saavedra-Santana P; Palop-Cubillo L
Am J Kidney Dis; 1999 Sep; 34(3):508-13. PubMed ID: 10469862
[TBL] [Abstract][Full Text] [Related]
10. [Significance of an assessment of medullary hematopoiesis and siderophilic bone marrow erythrokaryocytes in iron-deficiency anemia].
Haĭdukova SM; Vydyborets' SV
Lik Sprava; 2001; (3):36-9. PubMed ID: 11560023
[TBL] [Abstract][Full Text] [Related]
11. Erythroferrone and hepcidin levels in children with iron deficiency anemia.
Dulkadir R; Turna Saltoğlu G; Güneş A
BMC Pediatr; 2024 Apr; 24(1):240. PubMed ID: 38575873
[TBL] [Abstract][Full Text] [Related]
12. Ambient fine particulate matter aggravates atherosclerosis in apolipoprotein E knockout mice by iron overload via the hepcidin-ferroportin axis.
Wan Q; Yang M; Liu Z; Wu J
Life Sci; 2021 Jan; 264():118715. PubMed ID: 33160991
[TBL] [Abstract][Full Text] [Related]
13. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs.
Rivera S; Nemeth E; Gabayan V; Lopez MA; Farshidi D; Ganz T
Blood; 2005 Sep; 106(6):2196-9. PubMed ID: 15933050
[TBL] [Abstract][Full Text] [Related]
14. Presence of the iron exporter ferroportin at the plasma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin.
Delaby C; Pilard N; Gonçalves AS; Beaumont C; Canonne-Hergaux F
Blood; 2005 Dec; 106(12):3979-84. PubMed ID: 16081696
[TBL] [Abstract][Full Text] [Related]
15. Systemic Iron Deficiency in a Nonhuman Primate Model of Endometriosis.
Atkins HM; Appt SE; Taylor RN; Torres-Mendoza Y; Lenk EE; Rosenthal NS; Caudell DL
Comp Med; 2018 Aug; 68(4):298-307. PubMed ID: 29871715
[TBL] [Abstract][Full Text] [Related]
16. The association of TMPRSS6 gene polymorphism with iron status in Egyptian children (a pilot study).
Hamed HM; Bostany EE; Motawie AA; Abd Al-Aziz AM; Mourad AA; Salama HM; Kamel S; Hassan EM; Helmy NA; El-Saeed GS; Elghoroury EA
BMC Pediatr; 2024 Feb; 24(1):105. PubMed ID: 38341535
[TBL] [Abstract][Full Text] [Related]
17. A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease.
Olivari V; Di Modica SM; Lidonnici MR; Aghajan M; Cordero-Sanchez C; Tanzi E; Pettinato M; Pagani A; Tiboni F; Silvestri L; Guo S; Ferrari G; Nai A
Kidney Int; 2023 Jul; 104(1):61-73. PubMed ID: 36990212
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency.
Foka P; Dimitriadis A; Karamichali E; Kyratzopoulou E; Giannimaras D; Koskinas J; Varaklioti A; Mamalaki A; Georgopoulou U
Virulence; 2016 Aug; 7(6):679-90. PubMed ID: 27058404
[TBL] [Abstract][Full Text] [Related]
19. Serum hepcidin in clinical specimens.
Dallalio G; Fleury T; Means RT
Br J Haematol; 2003 Sep; 122(6):996-1000. PubMed ID: 12956771
[TBL] [Abstract][Full Text] [Related]
20. Iron status in patients with chronic heart failure.
Jankowska EA; Malyszko J; Ardehali H; Koc-Zorawska E; Banasiak W; von Haehling S; Macdougall IC; Weiss G; McMurray JJ; Anker SD; Gheorghiade M; Ponikowski P
Eur Heart J; 2013 Mar; 34(11):827-34. PubMed ID: 23178646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
